编者按：2015 年 10 月 8 号上午是 2015 美国外科年会最后半天，依然有 25 个学术报告先后进行着。经过反复的邮件沟通，小编终于在年会的最后一天见到了“交往许久的网友”——AME 旗下 Gland Surgery 杂志 2015 年十月“New Technology in Endocrine Surgery”专刊的作者，来自克利夫兰医学中心机器人内分泌外科主任 Eren Berber 教授，并邀请其解读当日所做的研究报告。
Please briefly introduce yourself.
In this year’s clinical congress, you have given a speech on “Clinical Application of a Planning Software for Laparoscopic Microwave Thermosphere Ablation of a Malignant Liver Tumor”. Could you here briefly share with us the main points of this study? What’s the significance?
Is there any possibility to promote this planning software to other area? Any limitation?
You are an expert in laparoscopic and robotic endocrine surgery. Could you give some instructions/suggestions to the young practitioners?
What do you love about surgery? Why did you choose to be a surgeon?
Dr. Eren Berber is an Associate Professor of Surgery at the Cleveland Clinic and currently is the director of Robotic Endocrine Surgery and co-director of Liver Tumor Ablation Program. He has been staff at the Department of General Surgery at the Cleveland Clinic, Ohio since 2005. His areas of interest include laparoscopic and robotic liver surgery, laparoscopic liver tumor ablation, robotic surgery, conventional and minimally invasive endocrine surgery (thyroid, parathyroid, adrenal and pancreas), robotic thyroidectomy, robotic adrenalectomy and surgical ultrasound.
Dr. Berber has authored 120 peer-reviewed papers and 15 book chapters. He is the director of Cleveland Clinic Annual Laparoscopic and Robotic Solid Organ course. He is on the Editorial Board of Surgical Laparoscopy and Endoscopy. He is an active member of numerous surgical societies, including American College of Surgeons and serves in multiple committees.
ACS 2015 专题
点击链接，查看 Dr. Berber 为“New Technology in Endocrine Surgery”专刊所撰文章“Laparoscopic and robotic adrenal surgery: transperitoneal approach”。